National Bank of Canada’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.3M Sell
592,194
-432,917
-42% -$11.9M 0.02% 512
2025
Q1
$29.1M Buy
1,025,111
+856,036
+506% +$24.3M 0.03% 353
2024
Q4
$7.03M Sell
169,075
-66,191
-28% -$2.75M 0.01% 693
2024
Q3
$15.7M Buy
235,266
+90,739
+63% +$6.06M 0.02% 470
2024
Q2
$16.8M Sell
144,527
-50,897
-26% -$5.9M 0.02% 378
2024
Q1
$22.9M Sell
195,424
-114,956
-37% -$13.5M 0.04% 300
2023
Q4
$34.9M Sell
310,380
-404,181
-57% -$45.5M 0.06% 248
2023
Q3
$73.8M Buy
714,561
+564,679
+377% +$58.3M 0.11% 135
2023
Q2
$18.2M Buy
149,882
+99,989
+200% +$12.2M 0.03% 331
2023
Q1
$7.7M Buy
49,893
+20,234
+68% +$3.12M 0.02% 421
2022
Q4
$5.33M Sell
29,659
-55,235
-65% -$9.92M 0.01% 541
2022
Q3
$10M Buy
84,894
+70,864
+505% +$8.38M 0.05% 327
2022
Q2
$2.03M Sell
14,030
-104,967
-88% -$15.2M 0.01% 662
2022
Q1
$20.3M Buy
118,997
+108,203
+1,002% +$18.5M 0.06% 216
2021
Q4
$2.69M Buy
+10,794
New +$2.69M 0.01% 621